Cataract Surgery Considerations for Diabetic Patients
- PMID: 34967932
- DOI: 10.1007/s11892-021-01418-z
Cataract Surgery Considerations for Diabetic Patients
Abstract
Purpose of review: Given the epidemiology and demographic trends of diabetes mellitus and cataracts, ophthalmologists are likely to encounter patients with both comorbidities at an increasing frequency. Patients with diabetes represent a higher risk population than healthy patients for cataract surgery. In this review, we discuss key risks and risk-mitigation practices when performing cataract surgery on these patients.
Recent findings: Patients with diabetes continue to represent a high-risk surgical population: Nagar et al. suggest a dose-dependent relationship may exist between number of intravitreal injections and likelihood of posterior capsular rupture. However, novel treatments are improving outcomes for patients with diabetes. Several studies have reported intracameral phenylephrine/ketorolac may reduce the incidence of post-operative cystoid macular edema while others have discussed the efficacy of pre-treatment and post-treatment with intravitreal bevacizumab on improving cataract surgery outcomes in patients with diabetic retinopathy. Pre-operatively, ophthalmologists should perform an enhanced evaluation, consider timing and lens selection decisions, and complete any appropriate pre-operative treatment. Peri-operatively, surgeons should be aware of pupillary dilation adjustments, combination surgery options, and potential complications. Post-operatively, clinicians should address pseudophakic cystoid macular edema, diabetic macular edema, diabetic retinopathy, and posterior capsular opacification.
Keywords: Cataract; Complication; Diabetes; Phacoemulsification; Risk.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
-
- Allen D, Vasavada A. Cataract and surgery for cataract. BMJ. 2006;333:128–132. http://www.v2020.org/main_page.asp.
-
- Hashemi H, Pakzad R, Yekta A, et al. Global and regional prevalence of age-related cataract: a comprehensive systematic review and meta-analysis. Eye (Basingstoke). 2020;34(8):1357–70. https://doi.org/10.1038/s41433-020-0806-3 . - DOI
-
- Bourne RRA, Steinmetz JD, Saylan M, et al. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the global burden of disease study. Lancet Glob Health. 2021;9(2):e144–60. https://doi.org/10.1016/S2214-109X(20)30489-7 . - DOI
-
- Kelly E, Wen Q, Haddad D, O’Banion J. Effects of an aging population and racial demographics on eye disease prevalence: projections for Georgia through 2050. Am J Ophthalmol. 2020;210:35–40. https://doi.org/10.1016/j.ajo.2019.10.028 . - DOI - PubMed
-
- Varma R, Vajaranant TS, Burkemper B, et al. Visual impairment and blindness in adults in the United States. JAMA Ophthalmol. 2016;134(7):802–9. https://doi.org/10.1001/jamaophthalmol.2016.1284 . - DOI - PubMed - PMC
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials